TEP’s 11.7
#TEP hit 11.7%; two reasons really - Adj PBT at lower end of guidance (so hasn't 'missed') and the change to Shareholder Return Policy with a minimum 50% Dividend, which would still be around 4%. With shares so low, Buybacks makes good sense.
FTSE250 Doji Signals Caution Near Support, Bullish EMAs
#FTSE250 doji Candle. Support 22087, 21557, 21000. Resistance 23231, 23844. RSI 53 just off Neutral. 13/21 day EMAs Bullish. Top Bollinger Band 23193. Midpoint Line 22811. Bottom Band 22440.
DAX Consolidates Near Resistance, Bullish EMAs Signal
#DAX doji Candle and Sideways. Resistance 24792. Support 23482, 23000. RSI 54 near Neutral. 13/21 day EMAs Bullish. Top Bollinger Band 24607. Midpoint Line 24225. Bottom Band 23832.
OHGR Beats Expectations Yet Remains Risky Play
#OHGR "ahead of market expectations". ShareScope showing fwd p/e 18.5 falling to 17.9 and fwd Divvy 2.6% rising to 2.7%, BEFORE today's news and allowing for cash. Illiquid but play on NHS failure. I don't hold.
PWR Posts OK Results, Announces 1.6p Dividend
#PWR maiden results read OK. Cash $15.3m (but most from IPO). ShareScope has fwd p/e 9.5 RISING to 11 (could be way out), but no Dividend forecasts; however PWR announced Dividend 1.6p per Share & ongoing "progressive Dividend policy". Illiquid...
ANP Cancels Repurchased Shares, Avoids Treasury Reissue
Notably shares bought back by #ANP will be cancelled. Far better than just being "held in Treasury" (where they can be reissued later).
FDA Approves Weekly Self‑Injectable Saphnelo for Lupus
#AZN Saphnelo for treating systemic lupus erythematosus, approved by US FDA for self-administration via a once a week autoinjector Pen.
Tesaro's Breach Claim Dismissed, Jemperli Licence Fight Persists
Looks like #GSK subsidiary TESARO Inc., has had a "claim for anticipatory breach" against AnaptysBio kicked out by Delaware Chancery Court. Principal contract dispute still ongoing though around Jemperli (Dostarlimab) licence agreement.
AIM Eyes Support as Bullish EMAs Hold
#AIM All Share small Down Candle. Support 774, 750, 726. Resistance 812, 837. RSI 61 not high. 13/21 day EMAs Bullish. Small Down Candle on Weekly. Top Bollinger Band 817. Midpoint Line 800. Bottom Band 782.
Nasdaq Hits New ATH, Overbought Yet Still Rising
#Nasdaq Comp New ATH 24854. Support 24199, 23000, 22501. RSI 70 Overbought but can go higher. Small Up Candle on Weekly. Top Bollinger Band 25140. Midpoint Line 24200. Bottom Band 23260.
Brent Oil Nears Bullish Breakout Amid Tight EMA Cross
#BrentOil Comp Doji Candle & Sideways. Resistance $103.9, $112.1. Support $91.4, $86.1, $80. Lining up MACD Bull Cross. RSI 55.5 near Neutral. Just done 13/21 day EMA Bull Cross but Lines tight. Up Candle on Wkly. Top Bollinger Band $103.5....
SQZ Beats Expectations, Reaffirms Guidance, Plans Organic Growth
Looks like #SQZ operating much better and reiterates FY Guidance. On 2nd June will do a Capital Markets Day and that will focus on "organic" growth options such as infill drilling.
JNEO's New Acquisition Gains £1m Utility
#JNEO recent acquisition Crime and Fire Defence won £1m of contracts within a 5 year Framework Agreement "with a major UK Utility". ShareScope has fwd p/e 13.2; not much to go on but not expensive. I don't hold.
OMG's £31.7m Cash Pile Fuels
The most interesting bit regarding #OMG is the Cash mountain of £31.7m. ShareScope is showing a Mkt Cap of £56.4m and fwd Divvy 6.7% rising to 7%. Worth considering. I don't hold.
S&P 500 Holds Near ATH, Support at 7000
#SP500 small Up Candle and Sideways near ATH 7147. Support 7000, 6905, 6740. RSI 67 high but not Overbought. Top Bollinger Band 7235. Midpoint Line 7000. Bottom Band 6773.
IGP Gains 8% on New Orders, Valuation Drops
#IGP won $3.8m over 3 new orders. ShareScope has fwd p/e 18 falling to 15.4 and no Dividend, BEFORE 8% jump today. Still interesting. I don't hold.
IHP Thrives, ShareScope's Valuation Improves, Dividend Up
#IHP Update reads well and Transact platform continues to grow. ShareScope has fwd p/e 17 falling to 15.2 and fwd Divvy 3.8% rising to 4.2%; lot to like and nice payout. I don't hold.
NICL Appears Cheap After Cash Strip, but I Stay Out
#NICL good Update. Net Cash £59.8m (up). Potential disruption from Middle East dramas. ShareScope has fwd p/e 12.9 falling to 12.1 and fwd Divvy 4.9% rising to 5.4%; strip out cash and it looks cheap. I don't hold.
AXS Shows Modest Accoya Growth, Yet Valuation Stretched
#AXS Update reads well with decent growth in Accoya volumes and value. ShareScope showing fwd p/e 31.7 2 years out; with debt it's a very high rating, so lot more growth needed.
XPS FY Update Boosts Appeal: Lower P/E, Higher Dividend
#XPS good FY Update, especially after a strong prior year. ShareScope has fwd p/e 14.8 falling to 13.7 and fwd Divvy 4% rising to 4.3%; still appealing.
FTSE250 Faces Minor Dip Amid Strong Bullish EMAs
#FTSE250 small Down Candle. Resistance 23231, 23844. Support 22627, 22000, 21373. RSI 63 not high. 13/21 day EMAs Bullish. Top Bollinger Band 23402. Midpoint Line 22500. Bottom Band 21645.
Dow Shows Bullish Bias Near Resistance, Strong Support
#DOW doji Candle. Resistance ATH 50512. Support 48788, 48000, 46978. RSI 64 not high. 13/21 day EMAs Bullish. Top Bollinger Band 49914. Midpoint Line 48338. Bottom Band 46762.
ELIX AI Growth, Lower P/E, Higher Dividend—Still Not a Buy
#ELIX good Update; AI seems to be a growth area for them. ShareScope showing fwd p/e 12.9 falling to 10.9 and fwd Divvy 3% rising to 3.5%; pretty reasonable valuation. I don't hold.
Revenue Beats, Backlog Record, P/E Improves, Dividend Rises
#KNOS "Revenue ahead of consensus", "Record backlog levels". ShareScope showing fwd p/e 21.5 falling to 18.1 and fwd Divvy 3.4% rising to 3.7%, BEFORE cash stripped out. Lot to like. I don't hold.
GSK's Blenrep Approved in China for Multiple Myeloma
#GSK Blenrep (belantamab mafodotin) approved in China with a Bortezomib and Dexamethasone combo for treating Adults with a form of multiple myeloma.
FTSE100 Holds Near 10,500, Eyes
#FTSE100 small Up Candle and Sideways, arguably a doji. Resistance ATH 10935. Support 10500, 10287, 10000. RSI 61 not high. 13/21 day EMAs Bullish. Doji on Weekly. Top Bollinger Band 10740. Midpoint Line 10561. Bottom Band 10380.
Bought TBTG at 311p, IPO Exceeds Expectations
BOUGHT #TBTG The Beauty Tech Group at 311p, about 1% of Portfolio Value (only cash I had sitting around). Recent IPO and off to a strong start with plenty of "ahead of expectations". I'll update website later. DYOR
Strong Growth, High Cash, but Overvalued Post‑IPO
#TBTG "Revenue and Profit growth exceeding expectations". Net Cash £40.8m. ShareScope has fwd p/e 19.8 falling to 14.2; quite low rating if cash stripped out. Recent IPO and interesting. I don't hold.
AVG Secures £10m Nuclear Orders, Shares Surge 7%
#AVG won "more than £10m" in Nuclear orders since Jan 1st. ShareScope showing fwd p/e 19.1 falling to 15.5 and fwd Divvy 0.9% each of next 2 years, BEFORE 7% jump today and the News. New ATH and a chart...
BOOM's Growth vs High Forward P/E Raises Rating Doubts
#BOOM Update reads well with decent growth in Revenue and Profit. ShareScope showing fwd p/e 39.3 falling to 27.4, and no Dividend. Does it justify the rating? I don't hold.
AIM Shares Show Bullish Momentum Near 820 Resistance
#AIM All Share small Up Candle, arguably a doji, but rising. Resistance 820, 837. Support 769, 750, 726. RSI 61.5 not high. 13/21 day EMAs Bullish. Top Bollinger Band 813. Midpoint Line 761. Bottom Band 710.
Nasdaq Hits New ATH, RSI Suggests Further Upside
#Nasdaq Comp big Up Candle and New ATH (just) 24026. Support 23331, 23000, 22501. RSI 65 not that high so more room for gains. Top Bollinger Band 24150. Midpoint Line 22684. Bottom Band 21245.
DAX Doji Near Resistance, Bullish EMA Cross Signals Caution
#DAX doji Candle at 50 and 200 day MA Lines. Resistance 24366, 24897, ATH 25507. Support 23482, 23000, 22677. RSI 54 bit off Neutral. Done 13/21 day EMA Bull Cross. Top Bollinger Band 24522. Midpoint Line 23557. Bottom Band 22593.
Brent Oil Near Neutral, Watch $90 Support, $100 Resistance
#BrentOil Comp Doji Candle and Sideways 6 days. Support $90.4, $84, $73.2. Resistance $100, $103.9, $112.1. RSI 52 near Neutral. 13/21 day EMAs Bullish but Lines converging. Doing 8/21 Bear Cross. Top Bollinger Band $110.7. Midpoint Line $100. Bottom Band...
BOWL Shows Strong Cash, Rising Dividend Despite Share Decline
#BOWL decent Update. Net Cash £26m. ShareScope has 11.8 falling to 11.1 and fwd Divvy 5% rising to 5.3%, BEFORE 6% rise today. Still interesting and good payout. I don't hold.
HFEL Offers 9.5% Yield, Yet High Risk
#HFEL update looks interesting. I note Dividend Yield last year was 9.5% on current share price. Invests in Asia incl China a bit. Full list of holdings in the report today. Perhaps it would work in Income Portfolio but quite...
S&P 500
#SP500 Up Candle near ATH 7002. Support 6790, 6740, 6600. RSI 61 not high. 13/21 day EMAs Bullish. Top Bollinger Band 7013. Midpoint Line 6715. Bottom Band 6425.
PROC Shows Strong Cash, Falling P/E, Yet Not
#PROC "ahead of exams". Net Cash up to £4.4m. ShareScope has fwd p/e 17.8 falling to 12.6 and fwd Divvy 4.7%, 2 years out. Seems in good shape after pandemic woes. I don't hold.
PRV Holds Steady, Worth Considering Despite Minor Weaknesses
#PRV in line. Some weakness in Autos bit but small part. Lumpy orders in Aerospace. ShareScope has fwd p/e 16.5 falling to 15.5 and fwd Divvy 1% each of next 2 years. Good business and worth considering. I don't hold.
ITRK Jumps 11% Amid Strategic Split Review
#ITRK strong start to year and reiterates guidance. Launch of Strategic Review which may split the company up. ShareScope has fwd p/e 14.4 falling to 13.3 and fwd Divvy 4.5% rising to 4.8%, BEFORE 11% jump today. Very interesting business....
FTSE250 Awaits Breakout Above 22,629 Amid Neutral RSI
#FTSE250 doji Candle and Sideways. Needs Breakout 22629. Support 22000, 21373. RSI 52 near Neutral. Lining up 13/21 day EMA Bull Cross. Top Bollinger Band 22828. Midpoint Line 21722. Bottom Band 20652.
EKF Acquires Real‑Time Glucose Tracker, P/E Declines
#EKF buying "Real-time glucose and lactate tracking for sports performance monitoring" from Beep Insights AB. ShareScope has fwd p/e 15.1 falling to 13.4 but no Dividend. Worth investigating. I don't hold.
JNEO Lands £1.7m Order; Still Fairly Valued
#JNEO won £1.7m of Purchase Orders for passenger displays "for a large local authority in the south of England". ShareScope has Fwd p/e 12.9; strip out cash and it's still a pretty reasonable rating. I don't hold.
NG Maintains Guidance Despite US
#NG. says in line with guidance at HY, apart from a small hit due to US Federal Energy Regulatory Commission ruling meaning customer refunds and higher than expected storm costs in US. ShareScope has fwd Dividend Yield 3.6% rising to...
UTG Boosts Buyback, Maintains 8% Dividend Yield
#UTG Update in line. Interesting actions on Disposals and intention to increase Buyback authority. ESP synergies on track. Valuation down due to higher yields. Energy costs hedged. ShareScope has fwd Dividend Yield 8.1% rising to 8.2%; a decent payout.
MEGP Lands Asda Deal; Lower P/E, Higher Yield
#MEGP won that Asda agreement for the Washing Machines. ShareScope has fwd p/e 9.1 falling to 8.2 and fwd Divvy 6.2% rising to 6.7%. Seems a low rating and decent payout. I don't hold.
IGP
#IGP revenue down but been winning orders. Net Cash now £20m against Mkt Cap about £50m. ShareScope has fwd p/e 15.9 falling to 13.7 before stripping cash out. I don't hold.
SOM Boosts Buyback to $6M, Details M&A Framework
#SOM increased Buyback Programme (previously announced) to $6m and given more details on M&A Framework. I don't recall much M&A previously so that's interesting.
AIM Up Candle Faces Bearish EMA, Neutral RSI
#AIM All Share big Up Candle. Resistance 782, 800, 820. Support 741, 726, 700. RSI 48 near Neutral. 13/21 day EMAs Bearish. Top Bollinger Band 760. Midpoint Line 727. Bottom Band 693.
Trump Threatens NATO Pullout, Praises Starmer’s Stance
Trump looking to punish NATO countries that were unhelpful right at the start. Could mean withdrawing American Forces from the countries. Well done Starmer (you tool).